Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer
, , y
07 abr 2022
Acerca de este artículo
Categoría del artículo: Research Article
Publicado en línea: 07 abr 2022
Páginas: 185 - 197
Recibido: 26 sept 2021
Aceptado: 28 ene 2022
DOI: https://doi.org/10.2478/raon-2022-0012
Palabras clave
© 2022 Jiwon Choi, Jiyoung Park, Ilyoung Cho, Yhunyhong Sheen, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Choi, Jiwon
College of Pharmacy, Ewha Womans UniversitySeoul, Republic of Korea
National Center for Efficacy Evaluation for Respiratory Disease Products, Korea Institute of ToxicologySeoul, Republic of Korea
Park, Jiyoung
College of Pharmacy, Ewha Womans UniversitySeoul, Republic of Korea
National Center for Efficacy Evaluation for Respiratory Disease Products, Korea Institute of ToxicologySeoul, Republic of Korea
Cho, Ilyoung
College of Pharmacy, Ewha Womans UniversitySeoul, Republic of Korea
Sheen, Yhunyhong
College of Pharmacy, Ewha Womans UniversitySeoul, Republic of Korea